Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis
Status:
Terminated
Trial end date:
2012-04-30
Target enrollment:
Participant gender:
Summary
Rheumatoid arthritis (RA) is the most common inflammatory arthritis and a major health
problem. The purpose of this study is to determine the safety and effectiveness of lovastatin
for controlling inflammation in mildly active RA.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)